Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
Senti Biosciences’ Business Combination with Dynamics Special Purpose Corp.
Dynamics Special Purpose’s $230 Million Initial Public Offering
Davis Polk advised Dynamics Special Purpose Corp. on the deal, while Simpson Thacher represented J.P. Morgan Securities LLC. Dynamics Special Purpose Corp. executed its $230 million...